1. Home
  2. LGND vs NATL Comparison

LGND vs NATL Comparison

Compare LGND & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • NATL
  • Stock Information
  • Founded
  • LGND 1987
  • NATL 2023
  • Country
  • LGND United States
  • NATL United States
  • Employees
  • LGND N/A
  • NATL N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • NATL
  • Sector
  • LGND Health Care
  • NATL
  • Exchange
  • LGND Nasdaq
  • NATL Nasdaq
  • Market Cap
  • LGND 2.0B
  • NATL 2.0B
  • IPO Year
  • LGND 1992
  • NATL N/A
  • Fundamental
  • Price
  • LGND $111.71
  • NATL $29.42
  • Analyst Decision
  • LGND Strong Buy
  • NATL Buy
  • Analyst Count
  • LGND 6
  • NATL 4
  • Target Price
  • LGND $144.83
  • NATL $35.50
  • AVG Volume (30 Days)
  • LGND 142.9K
  • NATL 384.8K
  • Earning Date
  • LGND 11-07-2024
  • NATL 11-12-2024
  • Dividend Yield
  • LGND N/A
  • NATL N/A
  • EPS Growth
  • LGND 160.46
  • NATL N/A
  • EPS
  • LGND 2.47
  • NATL N/A
  • Revenue
  • LGND $152,422,000.00
  • NATL $4,307,000,000.00
  • Revenue This Year
  • LGND $23.19
  • NATL $4.77
  • Revenue Next Year
  • LGND $15.08
  • NATL $2.62
  • P/E Ratio
  • LGND $45.20
  • NATL N/A
  • Revenue Growth
  • LGND N/A
  • NATL 3.58
  • 52 Week Low
  • LGND $57.00
  • NATL $18.42
  • 52 Week High
  • LGND $129.90
  • NATL $35.29
  • Technical
  • Relative Strength Index (RSI)
  • LGND 48.80
  • NATL 56.54
  • Support Level
  • LGND $119.69
  • NATL $28.12
  • Resistance Level
  • LGND $125.76
  • NATL $32.87
  • Average True Range (ATR)
  • LGND 5.73
  • NATL 1.30
  • MACD
  • LGND -0.30
  • NATL 0.29
  • Stochastic Oscillator
  • LGND 25.51
  • NATL 51.88

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a global customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. They manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications & Technology.

Share on Social Networks: